Central retinal vein occlusion: A case report and review of the literature

Cases Journal

Volumn 2, Issue 6, 2009, Pages

  Alasil, Tarek ^a   Lee, Nahyoung ^a   Keane, Pearse ^a   Sadda, Srinivas ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; BRIMONIDINE; CLONIDINE; HYDROCHLOROTHIAZIDE; LATANOPROST; TIMOLOL;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; ELECTROCARDIOGRAPHY; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; HYPERTENSION RETINOPATHY; INFORMATION RETRIEVAL; INTRAOCULAR PRESSURE; LABORATORY TEST; OPEN ANGLE GLAUCOMA; RISK FACTOR; SINUS RHYTHM; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 77953414552     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.1186/1757-1626-2-7170     Document Type: Article

References (15)

1. The Central Vein Occlusion Study Group: Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997, 115:486-491.
2. Mohamed Q, McIntosh RL, Saw SM, Wong, TY: Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007, 114:507.
3. Klein R, Moss SE, Meuer SM, Klein BE: The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008, 126:513.
4. Prisco D, Marcucci R: Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002, 32:308.
5. Cugati S, Wang JJ, Knudtson MD et al.: Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology 2007, 114:520.
6. Biousse V, Newman NJ, Sternberg P Jr: Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia. Am J Ophthalmol 1997, 124:257.
7. Freidman N, Kaiser P, Trattler W: Central retinal vein occlusion. Review of ophthalmology 2005, Chapter 11:329.
8. Bhagat N, Goldberg MF et al.: Central retinal vein occlusion: review of management. Eur J Ophthalmol 1999, 9:165-180.
9. Paul R. A. O'Mahoney, David T. Wang et al.: Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008, 126:692-699.
10. Rath EZ, Frank RN, Shin DH, Kim C: Risk factors for retinal vein occlusions. A case-Control Study Group. Ophthalmology 1992, 99:509-514.
11. Anon: Risk factors for central retinal vein occlusion. The eye disease Case-Control Study Group. Arch Ophthalmol 1996, 114:545-554.
12. Hayreh SS: Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005, 24:493-519.
13. Central Vein Occlusion Study Group: Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993, 111:1087.
14. The Central Vein Occlusion Study Group: A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The central vein occlusion study group N report. Ophthalmology 1995, 102:1434-1444.
15. Porodi, Maurizio Battaglia et al.: Panretinal photocoagulation and photodynamic therapy for anterior segment neovascularization secondary to ischemic central retinal vein occlusion. Ophthalmic surgery, Laser and Imaging 2007, 38:94-99.